Anthropic’s Mythos Model Cleared Boosts AI Access Markets
U.S. regulators have cleared broader access to Anthropic’s Mythos model after a brief regulatory stand-off over safet...
Which Cash Back Credit Cards Have No Annual Fee
Find out which cash back credit cards have no annual fee to suit your spending habits. Discover the perfect card for you today!
27,937 articles
Prosecutors Altered Title Policies in Major Bank Fraud Case
A real estate investor faces federal charges after authorities allege title policies were manipulated to secure an al...
Intel, AMD, and Applied Materials Slide on Chip Selloff
Chip stocks slipped as SK Hynix flagged weaker memory demand and a jump in oil prices threatened chip margins. The tr...
What Trump's Generic Drug Tariffs Could Cost Americans Now
Policy experts say what trump's generic drug tariffs could mean for prices and supplies is uncertain, with effects de...
Morning Minute: Autonomous Agents Fueled by Crypto
A new frontier is waking up: autonomous AI agents powered by crypto. This morning minute reveals how on-chain incenti...
Leading Claude Predicts Price Surge for XRP, SOL, ADA by 2026
Claude AI projects a multi-year rally for XRP, SOL, and ADA, with end-2026 targets that would mark fresh highs amid i...
IEA Releases Record 400 Million Barrels to Stabilize Markets
The International Energy Agency has authorized an unprecedented emergency release of 400 million barrels to blunt ene...
Bitcoin Price: Just Held; Fed Holds Rates, Lifts Inflation Forecast
The Federal Reserve left policy unchanged and raised its inflation forecast for 2026, shaking up expectations for cry...
Apple Cofounder Steve Wozniak Questions AI Hype Near 50th Anniversary
With Apple set to celebrate 50 years, Steve Wozniak’s skepticism about AI highlights a broader investor caution as ex...
Trump’s Bull Market Could Lift Tech ETF Gains in 30 Days
Tech-focused ETF VGT has rallied strongly, prompting analysts to weigh whether trump’s bull market could push another...
Viking Therapeutics Takeover Target in Biotech Investing?
Investors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
Forget Zepbound: Lilly's Next Stock Signal for Investors
Lilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status